Cargando…
Preclinical Modeling of DCD Class III Donation: Paving the Way for the Increased Use of This Challenging Donor Type
Deceased after circulatory death (DCD) donors offer a viable solution to the current organ shortage, particularly the Maastricht Class III (arrest subsequent to cessation of life support in the hospital). Although current results from these donors are very satisfactory, the number of included donors...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745153/ https://www.ncbi.nlm.nih.gov/pubmed/31565655 http://dx.doi.org/10.1155/2019/5924101 |
_version_ | 1783451497213722624 |
---|---|
author | Soussi, David Rod, Xavier Thuillier, Raphael Leblanc, Suzanne Goujon, Jean-Michel Barrou, Benoit Hauet, Thierry Kerforne, Thomas |
author_facet | Soussi, David Rod, Xavier Thuillier, Raphael Leblanc, Suzanne Goujon, Jean-Michel Barrou, Benoit Hauet, Thierry Kerforne, Thomas |
author_sort | Soussi, David |
collection | PubMed |
description | Deceased after circulatory death (DCD) donors offer a viable solution to the current organ shortage, particularly the Maastricht Class III (arrest subsequent to cessation of life support in the hospital). Although current results from these donors are very satisfactory, the number of included donors is too low and future expansion of inclusion criteria will likely decrease organ quality, with negative consequences on the complication rate. This donor type thus represents a priority in terms of scientific exploration, so as to study it in controlled settings and prepare for future challenges. Hence, we mimicked the DCD Class III clinical conditions a Large White pig model. Herein, we detail the different strategies attempted to attain our objectives, including technical approaches such as animal positioning and ventilator settings, as well as pharmacological intervention to modulate blood pressure and heart rate. We highlight the best combination of factors to successfully reproduce DCD Class III conditions, with perfusion pressures and functional warm ischemia (hypoperfusion) closely resembling clinical situations. Finally, we detail the functional and histological impacts of these conditions. Such a model could be of critical value to explore novel management alternative for these donors, presenting a uniquely adapted platform for such therapeutics as normothermic regional circulation and/or pharmacological intervention. |
format | Online Article Text |
id | pubmed-6745153 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-67451532019-09-29 Preclinical Modeling of DCD Class III Donation: Paving the Way for the Increased Use of This Challenging Donor Type Soussi, David Rod, Xavier Thuillier, Raphael Leblanc, Suzanne Goujon, Jean-Michel Barrou, Benoit Hauet, Thierry Kerforne, Thomas Biomed Res Int Research Article Deceased after circulatory death (DCD) donors offer a viable solution to the current organ shortage, particularly the Maastricht Class III (arrest subsequent to cessation of life support in the hospital). Although current results from these donors are very satisfactory, the number of included donors is too low and future expansion of inclusion criteria will likely decrease organ quality, with negative consequences on the complication rate. This donor type thus represents a priority in terms of scientific exploration, so as to study it in controlled settings and prepare for future challenges. Hence, we mimicked the DCD Class III clinical conditions a Large White pig model. Herein, we detail the different strategies attempted to attain our objectives, including technical approaches such as animal positioning and ventilator settings, as well as pharmacological intervention to modulate blood pressure and heart rate. We highlight the best combination of factors to successfully reproduce DCD Class III conditions, with perfusion pressures and functional warm ischemia (hypoperfusion) closely resembling clinical situations. Finally, we detail the functional and histological impacts of these conditions. Such a model could be of critical value to explore novel management alternative for these donors, presenting a uniquely adapted platform for such therapeutics as normothermic regional circulation and/or pharmacological intervention. Hindawi 2019-09-03 /pmc/articles/PMC6745153/ /pubmed/31565655 http://dx.doi.org/10.1155/2019/5924101 Text en Copyright © 2019 David Soussi et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Soussi, David Rod, Xavier Thuillier, Raphael Leblanc, Suzanne Goujon, Jean-Michel Barrou, Benoit Hauet, Thierry Kerforne, Thomas Preclinical Modeling of DCD Class III Donation: Paving the Way for the Increased Use of This Challenging Donor Type |
title | Preclinical Modeling of DCD Class III Donation: Paving the Way for the Increased Use of This Challenging Donor Type |
title_full | Preclinical Modeling of DCD Class III Donation: Paving the Way for the Increased Use of This Challenging Donor Type |
title_fullStr | Preclinical Modeling of DCD Class III Donation: Paving the Way for the Increased Use of This Challenging Donor Type |
title_full_unstemmed | Preclinical Modeling of DCD Class III Donation: Paving the Way for the Increased Use of This Challenging Donor Type |
title_short | Preclinical Modeling of DCD Class III Donation: Paving the Way for the Increased Use of This Challenging Donor Type |
title_sort | preclinical modeling of dcd class iii donation: paving the way for the increased use of this challenging donor type |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745153/ https://www.ncbi.nlm.nih.gov/pubmed/31565655 http://dx.doi.org/10.1155/2019/5924101 |
work_keys_str_mv | AT soussidavid preclinicalmodelingofdcdclassiiidonationpavingthewayfortheincreaseduseofthischallengingdonortype AT rodxavier preclinicalmodelingofdcdclassiiidonationpavingthewayfortheincreaseduseofthischallengingdonortype AT thuillierraphael preclinicalmodelingofdcdclassiiidonationpavingthewayfortheincreaseduseofthischallengingdonortype AT leblancsuzanne preclinicalmodelingofdcdclassiiidonationpavingthewayfortheincreaseduseofthischallengingdonortype AT goujonjeanmichel preclinicalmodelingofdcdclassiiidonationpavingthewayfortheincreaseduseofthischallengingdonortype AT barroubenoit preclinicalmodelingofdcdclassiiidonationpavingthewayfortheincreaseduseofthischallengingdonortype AT hauetthierry preclinicalmodelingofdcdclassiiidonationpavingthewayfortheincreaseduseofthischallengingdonortype AT kerfornethomas preclinicalmodelingofdcdclassiiidonationpavingthewayfortheincreaseduseofthischallengingdonortype |